Sabizabulin
id:
sabizabulin-205-2738371
title:
Sabizabulin
text:
Sabizabulin is an investigational new drug that is being evaluated for the treatment of castration-resistant prostate cancer and in SARS-CoV-2 (COVID-19) infections. It is a tubulin polymerization inhibitor. Sabizabulin is chemical compound from the group of indole and imidazole derivatives that was first reported in 2012 by Dalton, Li, and Miller.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Sabizabulin
date created:
2022-04-17T21:17:52Z
date modified:
2024-09-10T07:37:26Z
main entity:
{"identifier":"Q111600344","url":"https://www.wikidata.org/entity/Q111600344"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/6/66/Sabizabulin_structure.svg","width":745,"height":360}
fields total:
13
integrity:
16